Japan· JP-4291445D1029
ブリナツモマブ（遺伝子組換え）
A medicinal product containing ブリナツモマブ（遺伝子組換え）, registered in Japan by アムジェン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ブリナツモマブ（遺伝子組換え）
- Manufacturer
- アムジェン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ブリナツモマブ（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBlincytoAbacus Medicine A/S
- NorwayBlincytoAmgen Europe B.V.
- SwitzerlandBlincyto
- CzechiaBLINCYTOAmgen Europe B.V., Breda
- SpainBlincyto 38,5mcg de polvo para concentrado y solucion para solucion para perfusionAmgen Europe B.V.
- FranceBLINCYTO 38,5 microgrammes, poudre pour solution à diluer et solution pour solution pour perfusionAMGEN EUROPE
- United KingdomBlincyto 38.5micrograms powder for concentrate and solution for solution for infusion vialsAmgen Ltd
- IrelandBLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusionAmgen Europe B.V.,
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Blincyto
- Norway · Blincyto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/086c7e47-59e4-4246-b33e-10434b7a394c GET /v1/drugs/086c7e47-59e4-4246-b33e-10434b7a394c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３５μｇ１瓶（輸液安定化液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291445D1029",
"category": "注射薬",
"price_yen": 285961,
"generic_name": "ブリナツモマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about ブリナツモマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.